Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
1(8%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_3
1
8%
Ph not_applicable
1
8%
Ph phase_1
5
42%
Ph phase_4
1
8%
Ph phase_2
1
8%

Phase Distribution

5

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
5(55.6%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(7)
Terminated(2)
Other(1)

Detailed Status

Completed7
Withdrawn1
unknown1
Recruiting1
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (55.6%)
Phase 21 (11.1%)
Phase 31 (11.1%)
Phase 41 (11.1%)
N/A1 (11.1%)

Trials by Status

withdrawn18%
unknown18%
completed758%
recruiting18%
terminated18%
not_yet_recruiting18%

Recent Activity

1 active trials
Showing 5 of 12
not_yet_recruitingphase_1

Human Models of Selective Insulin Resistance: Pancreatic Clamp

NCT06558422
completedphase_1

Pancreatic Clamp in NAFLD

NCT05724134
recruitingphase_4

Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease.

NCT06939959
withdrawnphase_1

Dexamethasone/Pancreatic Clamp P&F

NCT06126354
unknownnot_applicable

Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes

NCT05095259
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT06558422Phase 1

Human Models of Selective Insulin Resistance: Pancreatic Clamp

Not Yet Recruiting
NCT05724134Phase 1

Pancreatic Clamp in NAFLD

Completed
NCT06939959Phase 4

Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease.

Recruiting
NCT06126354Phase 1

Dexamethasone/Pancreatic Clamp P&F

Withdrawn
NCT05095259Not Applicable

Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes

Unknown
NCT01492959

Observational Study With InnoLet® in Daily Clinical Practice

Completed
NCT00071448Phase 3

Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population

Completed
NCT01492205

NovoLet® Acceptance Study Within the Hospital Practise in Indonesia

Completed
NCT02028078Phase 2

Pilot Study Investigating the Feasibility of Determining the Endogenous Glucose Production During a Hypoglycaemia

Completed
NCT01511159Phase 1

Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers

Completed
NCT02382757

Changing Diabetes in Children

Terminated
NCT01269606Phase 1

Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12